Abstract
AbstractPharmacovigilance stands out for its importance in obtaining existing knowledge about medicine and patient safety and should be recognized as a continuous line of study. It constitutes a highly relevant component in the activities of health professionals, with spontaneous notification of suspected adverse drug reactions being its main emphasis. The underreporting that persists can be overcome through continuous professional development programs, reinforcing theoretical and practical knowledge in the curricular plans of health courses. As a result, more educated professionals will also allow citizens to recognize the importance of pharmacovigilance. The main objective of this study was to describe and characterize the teaching-learning process of pharmacovigilance in Portugal, analyzing the knowledge, perceptions and attitudes of students and health professionals. In total, ninety-three curricular unit forms of the seventeen healthcare courses included were analyzed, among which only three referred to pharmacovigilance as mandatory and thirty-nine did not address any keywords. The questionnaire applied was answered by 650 participants, both students (62%) and professionals (38%). Approximately 84.4% of the students and 54.7% of the professionals affirmed that they had never spontaneously reported an adverse drug reaction. Only 24.6% of the students and 17.8% of professionals referred to the existence of specific course content dedicated to pharmacovigilance in their coursework. In view of these results, it is evident that there is a need for a wider reflection regarding the further training and constant update of practicing professionals as well as in diverse health institutions, investing in the creation of an academic curriculum that integrates pharmacovigilance in healthcare courses.
Funder
Fundação para a Ciência e a Tecnologia, IP national support through CHRC – Comprehensive Health Research Centre
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Soares S, Roque F, Teixeira Rodrigues A, Figueiras A, Herdeiro MT. Safety alerts: an observational study in Portugal. Clin Ther. 2015;37(9):2122–8.
2. World Health Organization. Drug Safety of Medicines. World Health Organization Geneva. 2002;2:20.
3. World Health Organization. The Importance of Pharmacovigilance. 2002.
4. INFARMED IP. Farmacovigilância em Portugal 25 anos +. 2018.
5. EMA, Module. XVI – Risk minimisation measures: selection of tools and effectiveness indicators (Rev 2). RegS09 [Internet]. 2017;(February):1–47. Available from: http://www.jfda.jo/Download/JPC/TheGoodPharmacovigilancePracticev2.pdf